This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundLung transplantation (LTx) is the definitive treatment for end-stage pulmonary diseases, with venoarterial extracorporeal membrane oxygenation (VA-ECMO) used as a common perioperative support. Patients were divided into central (n=31) and peripheral (n=91) groups.
Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality.Results:From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5
Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundThe modified Blalock‐Taussig‐Thomas shunt is the gold standard palliation for securing pulmonary blood flow in infants with ductal‐dependent pulmonary blood flow. 1.99]) or freedom from catheter reintervention (OR, 1.02 [95% CI, 0.65–1.58]),
Background:Patients with Fontan palliation have reduced aerobic capacity because of impaired cardiac, pulmonary, and skeletal muscle function. We assessed the correlates of predicted peak VO2, and the relationship between predicted peak VO2quartiles and cardiovascular outcomes (death/transplant).Results:Of 15.2 - 23.9)
CT angiogram chest: no aortic dissection or pulmonary embolism. Serial chest xrays: progressive bilateral pulmonary edema. The last information available is that the patient was undergoing heart transplant evaluation. She died before she could get a heart transplant. No further troponins were measured.
CXR confirmed bilateral pulmonary edema and bilateral small effusions. 756-764 Google Scholar == MY Comment , by K EN G RAUER, MD ( 6/3 /2023 ): == Today's case is gratifying — in that it illustrates an uncommon phenomenon that Dr. J Electrocardiol, 42 (2009), pp. J Electrocardiol, 42 (2009), pp.
Stunning topline results from Merck Winrevair’s Phase 3 ZENITH trial found that the drug significantly reduced morbidity and mortality risks in patients with pulmonary arterial hypertension, paving the way for stronger commercialization and further functional trials. Adverse events weren’t serious, but headache (24.5%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content